Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.
Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.
Hepatology International|November 18, 2023
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancerAo Huang, De-Zhen Guo, Xuan Zhang, et al.
Plos One|October 15, 2011
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantationJie Hu, Zheng Wang, Jia Fan, et al.
Cancer Letters|December 10, 2025
Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib responseShi-Yu Zhang, De-Zhen Guo, Xin Zhang, et al.
Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Journal of Translational Medicine|October 1, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumorsDao-Han Zhang, Chen Liang, Shu-Yang Hu, et al.
Cancer Medicine|September 20, 2022
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II studyGuo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, et al.
Nature Communications|January 20, 2024
Macro CD5L<sup>+</sup> deteriorates CD8<sup>+</sup>T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinomaJia-Cheng Lu, Lei-Lei Wu, Yi-Ning Sun, et al.
Pageof 3